Talk:Intraductal carcinoma of the prostate: Difference between revisions
Jump to navigation
Jump to search
→BRCA2: new section |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
https://pubmed.ncbi.nlm.nih.gov/30808988/ | https://pubmed.ncbi.nlm.nih.gov/30808988/ | ||
== IDCP in GG1 == | |||
https://pmc.ncbi.nlm.nih.gov/articles/PMC10669759/ | |||
*IDC-P should graded to avoid overuse of basal cell stains | |||
**Exception to the rule: IDCP with GG1 or pure IDCP | |||
Latest revision as of 16:21, 14 October 2026
BRCA2
https://pubmed.ncbi.nlm.nih.gov/30808988/
IDCP in GG1
https://pmc.ncbi.nlm.nih.gov/articles/PMC10669759/
- IDC-P should graded to avoid overuse of basal cell stains
- Exception to the rule: IDCP with GG1 or pure IDCP